Introduction
============

Cilia and flagella are homologous, microtubule-based organelles found on diverse cell types ranging from spermatozoa to the epithelia lining the respiratory and reproductive tracts. The driving force for motility is supplied by the axonemal dynein ATPases. Defects in the dynein motors, accessory proteins that regulate dynein activity, or other components that control axoneme assembly have profound consequences. In vertebrates, these include infertility, respiratory and kidney disease, and defects in the determination of the left--right body axis during embryonic development ([@bib1]; [@bib27]; [@bib46]; [@bib31]; for review see [@bib50]). In motile axonemes, dyneins form the inner and outer arms that are bound to the outer doublet microtubules and interact transiently with adjacent doublet microtubules to generate the force for interdoublet sliding (for review see [@bib18]). Because dyneins can generate sliding forces in only one direction ([@bib43]; [@bib8]), the activity of the dynein arms must be coordinated both spatially and temporally to generate an efficient flagellar waveform.

Both structural and genetic evidence have implicated the central pair (CP)[\*](#fn1){ref-type="fn"} and radial spoke (RS) structures as key regulators of dynein activity. Mutations that disrupt the CP or RS structures result in flagellar paralysis under physiological conditions ([@bib56]), by a mechanism that appears to involve global inactivation of the dynein arms ([@bib16]; [@bib49]). One hypothesis is that the CP projections act like a distributor that periodically sweeps past the RS heads during CP rotation, inducing a local signal that is ultimately transmitted to the dynein arms ([@bib29]; [@bib30]). In the absence of these signals, other axonemal components must inhibit dynein activity. Evidence for such an inhibitory control system has been obtained by the isolation of extragenic suppressor mutations that restore partial motility to CP/RS-defective strains without restoring the missing structures ([@bib16]; [@bib35]). Two distinct groups of suppressor mutations have been identified. One group alters the activity of the outer dynein arms by mutations in dynein heavy chain domains that regulate cross-bridge activity ([@bib16]; [@bib38]; [@bib41]). The second group alters the assembly of the inner dynein arms and/or a subset of closely associated polypeptides known as the dynein regulatory complex (DRC) ([@bib16]; [@bib35], [@bib36]; [@bib37]; [@bib10]). The mechanism by which the DRC regulates dynein activity is still unclear.

The DRC contains at least seven polypeptides that are tightly associated with the outer doublet microtubules ([@bib36]), but until this study, the identity of any of these DRC subunits has been unknown. The DRC has also been correlated with a crescent-shaped structure located near the base of the second RS, close to the site of attachment for the nexin link ([@bib4]; [@bib24]; [@bib10]; [@bib57]). This structure appears to be ideally situated to mediate local signals between the CP/RS complex, the nexin links, and the dynein arms, and it is altered or missing in DRC-defective strains ([@bib24]; [@bib10]). It is unclear whether the local signals that control dynein arm activity are chemical, mechanical, or both. However, both pharmacological and biochemical evidence suggest that ciliary and flagellar motility is regulated in part by reversible phosphorylation of axonemal components (for review see [@bib40]). Several kinases and phosphatases are anchored in the axoneme ([@bib44]; [@bib58]; [@bib59]; [@bib9]; [@bib48]), and numerous axonemal phosphoproteins have been detected ([@bib34]). Recent studies also show that components of the dynein arms are targets of reversible phosphorylation, and that changes in their phosphorylation state can modulate dynein activity and flagellar motility ([@bib12]; [@bib11]; [@bib19]; [@bib58]).

To identify axonemal components that regulate dynein activity, we used insertional mutagenesis procedures in *Chlamydomonas* ([@bib51]) to recover "tagged" motility mutants with characteristics similar to previously described DRC mutants ([@bib16]; [@bib10]). Structural, functional, and genetic evidence indicate that we have cloned the *PF2* locus, which encodes DRC subunit 4, a highly coiled-coil protein of ∼55 kD that is tightly associated with the outer doublet microtubules. Localization of an epitope-tagged PF2 construct indicates that PF2 is uniformly distributed along the length of the axoneme and also associated with the basal body region. Interestingly, homologues of PF2 have recently been identified in diverse organisms, ranging from trypanosomes (trypanin) to humans (Gas8/Gas11), where they have been proposed to play important, but poorly understood, roles in both cell motility and growth arrest ([@bib2]; [@bib17]; [@bib60]). Our study strongly suggests that these PF2/trypanin/Gas8/Gas11 homologues are part of a conserved DRC complex involved in the regulation of axonemal motility in multiple species. The presence of *Gas8/Gas11* transcripts in growth-arrested cells and tissues that do not assemble motile axonemes ([@bib2]; [@bib55]; [@bib60]; unpublished data) may also indicate a possible role for the DRC in other microtubule-based organelles.

Results
=======

Recovery of a tagged *pf2* allele
---------------------------------

A collection of motility mutants generated by insertional mutagenesis was screened for strains with abnormal swimming behaviors to identify new loci involved in the regulation of motility. One strain, 9B11, swam more slowly than wild-type cells (∼51 ± 14 μm/s vs. 139 ± 24 μm/s) and displayed an aberrant flagellar waveform similar to those seen in inner arm and DRC mutant strains ([@bib3]; [@bib10]). Direct comparison between different strains by phase contrast microscopy indicated that 9B11 was most similar to the DRC mutant *pf2*. 9B11 was backcrossed to a *nit* ^−^ strain with wild-type motility to verify that the 9B11 motility defect was linked to the *NIT1* gene used as a selectable marker. Analysis of the tetrad progeny confirmed that the 9B11 motility phenotype cosegregated with the *nit* ^+^ phenotype (\<6.3 cM apart).

Cloning and characterization of the *PF2* gene
----------------------------------------------

To identify the gene that was disrupted in 9B11, a fragment of genomic DNA flanking the site of plasmid insertion was obtained by screening a size-fractionated minilibrary with a probe derived from the 3′ end of the *NIT1* gene (see Materials and methods; [Fig. 1](#fig1){ref-type="fig"} Figure 1.**Cloning the *PF2* gene.** (A) Partial restriction maps of the region containing the *PF2* gene from wild-type and *pf2-4* (9B11). Also indicated is the location of the *NIT1* plasmid insertion in 9B11, now known as *pf2-4*, and the position of the flanking clone FC-1 (black box) representing the NotI/BamHI restriction fragment recovered from the 9B11 minilibrary. S, SacI sites; N, NotI sites. (B) Southern blot of wild-type (wt) and *pf2-4* genomic DNA digested with the indicated restriction enzymes and hybridized with FC-1. (C) Alignment of three overlapping phage clones recovered with FC-1 (black boxes) and two plasmid clones, derived from λG1, that contain the *PF2* gene. Plasmid p9-3HA is the epitope-tagged *PF2* construct. Also shown are the number of rescued strains obtained by cotransformation of *pf2-4* and *pf2-1* with the selected clones. nd, not determined. A). Southern blots of wild-type and 9B11 genomic DNA probed with the flanking DNA (flanking clone 1 \[FC-1\]) confirmed that this DNA was located near the site of the mutation in 9B11 ([Fig. 1](#fig1){ref-type="fig"} B).

FC-1 was then used to screen a wild-type library and recover more than 30 kb of genomic DNA ([Fig. 1](#fig1){ref-type="fig"} C). RFLP mapping procedures revealed that this DNA was closely linked to the *PF2* locus on linkage group XI (see Materials and methods). These results and the 9B11 motility phenotype described above suggested that 9B11 might represent a new *pf2* mutation. To test if any of the phage clones contained a full-length copy of the *PF2* gene, three clones were analyzed for their ability to rescue the 9B11 and *pf2* motility defects by cotransformation. Two clones, λG2 and λJ1, were able to restore wild-type motility to either 9B11 or *pf2-1* cells ([Fig. 1](#fig1){ref-type="fig"} C). The 9B11 strain was therefore renamed *pf2-4*. The λM2 clone, which shares ∼50% overlap with λG2, failed to rescue the motility defects, suggesting that the *PF2* gene must extend beyond the limits of this clone.

Selected restriction fragments from the phage clones were used to probe Southern and Northern blots to define the boundaries of the *PF2* gene. Genomic Southern blots probed with subclones A--D indicated that the *NIT1* plasmid inserted into a 3.5-kb SacI restriction fragment without significant deletion of the surrounding genomic DNA in *pf2-4* ([Fig. 2](#fig2){ref-type="fig"} Figure 2.**Analysis of the *PF2* transcription unit.** (A) Partial restriction map of wild-type genomic DNA in the region of the *PF2* transcription unit. Also shown are selected SacI fragments (A, C, and D) and a NotI fragment (B) that were used to map the boundaries of the plasmid insertion and determine the size of the transcription unit. (B) Northern blot loaded with total RNA isolated from wild-type (wt) and *pf2* mutant cells before (0) and 45 min after deflagellation. This blot was hybridized with probe C, which recognized an ∼2.5-kb transcript that is up-regulated in wild-type cells and missing in *pf2* mutants. (B, bottom) Loading control. The blot was rehybridized with a *CRY1* probe, which encodes the ribosomal S14 protein subunit ([@bib26]). (C) Diagram of the intron--exon structure of the *PF2* transcription unit. Open rectangles indicate exons and solid lines indicate introns. The predicted translation start (ATG) site and the putative polyadenylation signal (Poly A) are indicated. Also shown are the single nucleotide alterations that resulted in the *pf2-1* and *pf2-2* mutations, and the location of the epitope tag in exon 12. A). Subclones A--D were also hybridized to Northern blots loaded with total RNA isolated from wild-type and mutant cells both before and 45 min after deflagellation to delineate the boundaries of the *PF2* transcription unit and determine the size of the *PF2* transcript. Deflagellation has previously been shown to induce up-regulation of transcripts that encode flagellar proteins (for review see [@bib22]). Probes B--D identified a single ∼2.5-kb transcript that was up-regulated after deflagellation in wild-type cells and missing in *pf2* strains ([Fig. 2](#fig2){ref-type="fig"} B). Given the location of the *NIT1* insertion in *pf2-4* and the expression pattern of the 2.5-kb transcript, we identified this region as the site of the *PF2* transcription unit. Probes A and B also hybridized to a smaller ∼2.2-kb transcript that was expressed in both wild-type and *pf2* cells and showed homology to a 50S ribosomal subunit ([Fig. 2](#fig2){ref-type="fig"} A).

The *PF2* transcription unit contains 12 exons and 11 introns spanning ∼5.7 kb of genomic DNA ([Fig. 2](#fig2){ref-type="fig"} C). All splice junctions were confirmed by sequence analysis of RT-PCR products derived from the wild-type *PF2* transcript. A subsequent search of the *Chlamydomonas* EST database has also identified a cDNA clone (BE056668) whose partial sequence closely matches the predicted sequence of the *PF2* transcript. PCR with gene-specific primers was then used to identify the mutations in two previously isolated *pf2* alleles, *pf2-1* and *pf2-2* ([@bib6]; [@bib16]). Sequence analysis of *pf2-1* DNA revealed a single base (G→T) mutation that results in an in-frame stop codon in exon 7 ([Fig. 2](#fig2){ref-type="fig"} C). Interestingly, probes B and C ([Fig. 2](#fig2){ref-type="fig"} A), which contain the DNA encoding exons 1--6, did not detect any transcript on Northern blots of *pf2-1* total RNA ([Fig. 2](#fig2){ref-type="fig"} B), which suggested that the *pf2-1* transcript may be unstable and/or rapidly degraded. Sequence analysis of *pf2-2* DNA revealed a single base (G→A) mutation that altered the donor splice site of exon 1 ([Fig. 2](#fig2){ref-type="fig"} C). Failure to recognize the altered sequence as a splice site would result in translation of the adjacent intron, which contains an in-frame stop codon 30 bp downstream of the altered splice site.

Suppression of flagellar paralysis by *pf2-4*
---------------------------------------------

*pf2* mutants belong to a group of bypass suppressor mutations that are capable of restoring motility to paralyzed RS or CP mutants without restoring the missing RS or CP structures ([@bib16]; [@bib36]). *pf2* mutations also alter the assembly of the DRC polypeptides, which are thought to be regulatory components located between the RS and the dynein arms ([Table I](#tbl1){ref-type="table"} Table I.Dynein regulatory complex subunitsSubunitMolecular mass[a](#tfn1){ref-type="table-fn"}Polypeptide deficiency in[a](#tfn1){ref-type="table-fn"} ^,^ [b](#tfn2){ref-type="table-fn"}Gene product ofkD183*pf3*, *sup-pf-5PF3* [c](#tfn3){ref-type="table-fn"}270*pf3*, *sup-pf-5*Unknown362*pf2*, *sup-pf-3*Unknown455*pf2*, *sup-pf-3PF2* [c](#tfn3){ref-type="table-fn"} ^,^ [d](#tfn4){ref-type="table-fn"}540*pf2*, *pf3*, *sup-pf-3, sup-pf-4, sup-pf-5SUP-PF-4* [b](#tfn2){ref-type="table-fn"} ^,^ [c](#tfn3){ref-type="table-fn"}629*pf2*, *pf3*, *sup-pf-3*, *sup-pf-4*, *sup-pf-5*Unknown7192*pf2*Unknown[^1][^2][^3][^4]; [@bib35]; [@bib10]). To test whether *pf2-4* can also act as a suppressor, *pf2-4* was crossed to a paralyzed, RS mutant, *pf14*, and the motility phenotypes of the resulting progeny were analyzed. The *pf2-4 pf14* cells had a motility phenotype that differed from either parent strain or wild-type cells ([Table II](#tbl2){ref-type="table"})Table II.Strains used in this workStrainStructural defectMotility phenotypeReferenceWild-type (137c)NoneFast forward swimming[@bib13]*nit1*Δ (A54e18)NoneFast forward swimming[@bib26]*pf2-1* (CC1025)DRC, inner arm regionSlow forward swimming[@bib6]*pf2-2* (*pf2A*, CC2503)DRC, inner arm regionSlow forward swimming[@bib16]*pf2-4* [a](#tfn5){ref-type="table-fn"} (9B11)DRC, inner arm regionSlow forward swimmingThis study*pf2-1* rescueNoneFast forward swimmingThis study*pf2-4* rescueNoneFast forward swimmingThis study*arg2*NoneFast forward swimming[@bib13]*arg7*NoneFast forward swimming[@bib13]*pf2-1 arg2*DRC, inner arm regionSlow forward swimmingThis study*pf2-4 arg7*DRC, inner arm regionSlow forward swimmingThis study*pf14*Radial spokesParalyzed[@bib34]*pf2-4 pf14*Radial spokes and DRCLimited motility[b](#tfn6){ref-type="table-fn"}This study[^5][^6]. The double mutants displayed vigorous flagellar movements, but they could generate little or no forward progress. This type of motility is similar to that seen with other suppressed strains containing defects in the DRC and RS ([@bib16]; [@bib35]; unpublished data).

Structural defects in the DRC
-----------------------------

To determine if the *pf2-4* motility phenotype was also associated with structural defects in the DRC, axonemes were isolated from wild-type and *pf2-4* cells and prepared for EM. Analysis of longitudinal sections with image-averaging procedures revealed a defect in a crescent-shaped structure located close to the second RS, within the 96-nm axoneme repeat ([Fig. 3, A and B](#fig3){ref-type="fig"})Figure 3.**Structural defects in *pf2* axonemes.** Longitudinal images of wild-type and mutant axonemes were aligned and computer image averaged. Shown here are grand averages of axonemes isolated from (A) wild type, (B) *pf2-4*, (C), *pf2-1*, and (D) a rescued *pf2* strain (*pf2-4*r). The arrows in A--D indicate the region of the 96-nm repeat that is occupied by the DRC structure. (E) Model of axoneme structures within the 96-nm axoneme repeat. The proximal and distal RSs are labeled S1 and S2, respectively; the outer dynein arms (OA) are shown on top, and the DRC is indicated as a crescent-shaped structure above the distal RS (S2). Difference plots between wild type (wt) and *pf2-4* (F), and wt and *pf2-1* (G) demonstrate that the DRC is missing in both mutants. Note that the DRC is restored in the rescued strain, *pf2-4*r (D).. This defect is very similar to the defect previously observed in *pf2-1* ([Fig. 3](#fig3){ref-type="fig"} C; [@bib24]; [@bib10]). The defects can be more clearly seen in the difference plots ([Fig. 3, F and G](#fig3){ref-type="fig"}), where the darkened regions represent the statistically significant differences between wild-type and *pf2* axonemes. The missing densities correspond to the structure previously identified as the likely location of the DRC polypeptides ([@bib10]). Significantly, the recovery of wild-type motility after transformation of *pf2-4* with the wild-type *PF2* gene was also associated with the reassembly of the DRC structure in the rescued strain ([Fig. 3](#fig3){ref-type="fig"} D).

Localization of the PF2 polypeptide and molecular complex formation
-------------------------------------------------------------------

Previous studies have shown that *pf2* axonemes lack five axonemal polypeptides known as DRC subunits 3--7 ([Table I](#tbl1){ref-type="table"}; [@bib16]; [@bib35], [@bib36]). Dikaryon rescue experiments tentatively identified DRC subunit 4 as the gene product of the *PF2* locus ([@bib36]). To determine if *PF2* encodes a structural component of the axoneme or a polypeptide extrinsic to the axoneme that is required for assembly of the DRC, an epitope-tagged construct was used to rescue the *pf2* mutant phenotype. PF2 is predicted to contain numerous coiled-coil domains throughout its length ([Fig. 4](#fig4){ref-type="fig"} Figure 4.**PF2 protein structure and epitope tagging.** (A) Diagrammatic representation of the domain structure of the PF2 polypeptide. Indicated are predicted coiled-coil domains (gray, shaded boxes) and the location of the epitope tag. (B) Western blot analysis of whole axonemes isolated from wild type, *pf2-4*, and a *pf2-4* strain rescued with the epitope-tagged *PF2* gene (*pf2-4*r:3HA). Blots were visualized with a reversible total protein stain (left) before immunolabeling with an antibody directed against the HA epitope (right). The HA antibody recognized a single band in *pf2-4*r:3HA migrating at ∼60 kD. A). The epitope tag was therefore inserted into the 12th exon of the *PF2* gene to avoid possible disruption of the coiled-coil domains and their potential functions ([Fig. 2](#fig2){ref-type="fig"} C; [Fig. 4](#fig4){ref-type="fig"} A). The resulting construct (p9-3HA) is predicted to encode a 60-kD polypeptide with a triple HA epitope tag inserted between aa 458 and 459 of the PF2 sequence. Cotransformation with the epitope-tagged transgene rescued the aberrant motility phenotype of *pf2-4* cells with high efficiency, and the rescued strains swam forward at wild-type velocities (e.g., 127 ± 14 μm/s), demonstrating that the presence of the epitope tag does not interfere with the function of PF2 ([Fig. 1](#fig1){ref-type="fig"} C). Axoneme samples from wild-type, *pf2-4*, and rescued *pf2-4* strains were analyzed on Western blots probed with an antibody directed against the HA epitope. A single polypeptide migrating at ∼60 kD was observed exclusively in the epitope-tagged, rescued strain ([Fig. 4](#fig4){ref-type="fig"} B), which indicates that PF2 is a structural component of the isolated axoneme. The size of the epitope-tagged PF2 is consistent with the hypothesis that *PF2* encodes DRC subunit 4 ([@bib36]).

Mutant and rescued cells were stained with antibodies against the HA epitope to analyze the subcellular distribution of PF2. Analysis of *pf2* mutant and *pf2* rescued cells by differential interference contrast microscopy demonstrated that both strains assemble full-length flagella ([Fig. 5, A, C, and E](#fig5){ref-type="fig"})Figure 5.**Localization of the epitope-tagged PF2 protein in *Chlamydomonas* flagella.** The epitope-tagged, rescued strain, *pf2-4*r:3HA, was stained with an antibody against the HA tag and then imaged by differential interference contrast (A and C) or indirect immunofluorescence light microscopy (B and D). The HA-tagged PF2 is present along the entire length of the flagella in *pf2-4*r:3HA cells and can also been seen in two spots in the basal body region (B and D). *pf2-4* mutant (E and F) or wild-type cells (G and H) labeled with the HA antibody or secondary antibody alone (not depicted) show only background cell body autofluorescence.. Staining with the HA antibody revealed that the tagged PF2 is present along the entire length of the flagella in the *pf2-4* rescued strain ([Fig. 5, B and D](#fig5){ref-type="fig"}) but missing in control samples ([Fig. 5, F and H](#fig5){ref-type="fig"}). The tagged PF2 was also visible in two spots at the anterior end of the cell in the rescued strain ([Fig. 5, B and D](#fig5){ref-type="fig"}). This site corresponds to the predicted location of the two basal bodies. The faint cell body staining seen in *pf2* and wild-type cells ([Fig. 5, F and H](#fig5){ref-type="fig"}) appeared to result from autofluorescence, as a similar pattern was observed after treatment with secondary antibody alone.

Based on the high incidence of coiled-coil domains in the predicted tertiary structure of PF2, it is likely that PF2 interacts with other axonemal polypeptides, specifically other components of the DRC and outer doublet microtubules. To identify those polypeptides, isolated axonemes from the HA-tagged strain were treated with varying concentrations of the zero-length cross-linker 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC) and then analyzed on Western blots. EDC has previously proven useful in the identification of interactions between subunits of several other axonemal structures (for examples see [@bib20]; [@bib59]). After a 1-h exposure of isolated axonemes to 1 mM EDC, three new bands migrating at ∼125, 130, and 145 kD, as well as a number of higher molecular mass (\>250 kD) bands, could be detected ([Fig. 6](#fig6){ref-type="fig"})Figure 6.**Identification of polypeptides that interact with PF2.** Axonemes from the HA-tagged *pf2-4* rescued strain were treated with 0, 1, 5, or 10 mM EDC and then used to prepare four identical Western blots. The first blot was stained for total protein. The remaining blots were labeled with antibodies directed against either the HA epitope (HA), α-tubulin (YOL 1/34), or β-tubulin (Tu27B). Asterisks mark three cross-linked products formed as a result of treating the HA-tagged PF2 axonemes with 1 mM EDC.. The PF2 cross-linked products did not react on Western blots with antibodies to α- and β-tubulin ([Fig. 6](#fig6){ref-type="fig"}). Rather, the sizes of the PF2 cross-linked products suggest instead a close association of PF2 with three polypeptides of ∼65, 70, and 85 kD. These results are consistent with the proposal that PF2 is part of a discrete complex of axonemal polypeptides.

*PF2* encodes the *Chlamydomonas* homologue of Gas11/Gas8
---------------------------------------------------------

The *Chlamydomonas PF2* gene is predicted to encode a 471-aa polypeptide ([Fig. 7](#fig7){ref-type="fig"} Figure 7.**PF2 homologues.** (A) Clustal W alignment of the deduced amino acid sequence of the *Chlamydomonas reinhardtii* (Cr) *PF2* gene (AY309087--AY309089) with homologues identified by BLAST. The shaded areas represent identical or conservatively substituted amino acids in \>50% of the sequences. The underlined region represents a putative microtubule-binding domain identified in the trypanosome and human orthologues ([@bib15]). The abbreviation and GenBank/EMBL/DDBJ accession nos. for the sequences are as follows: *Danio rerio* (Dr), [AI584969](AI584969); *Drosophila melanogaster* (Dm), [AE003427](AE003427) and [AA440118](AA440118); *Homo sapiens* (Hs), [AF050079](AF050079); *Mus musculus* (Mm), [U19859](U19859); *Trypanosoma bruzi* (Tb), [AAB81499](AAB81499); and *Trypanosoma cruzi* (Tc), [AQ44061](AQ44061). Gas11, growth arrest--specific 11; Gas8, growth arrest--specific 8. (B) Phylogenetic analysis of the Cr PF2 sequence and its homologues. A) with a molecular mass of ∼55 kD and pI of 6.66. Database searches reveal that PF2 is closely related to the growth arrest--specific gene product known as *Gas11* in humans and *Gas8* in mice ([@bib55]; [@bib60]). PF2 shares \>53% identity and 73% similarity with Gas11 and Gas8 ([Fig. 7](#fig7){ref-type="fig"} A). Significant homology is also observed between PF2 and Gas11/Gas8 orthologues found in zebrafish (*Danio rerio*), flies (*Drosophila melanogaster*), and trypanosomes (*Trypanosoma brucei*) ([Fig. 7](#fig7){ref-type="fig"} A). PF2 homologues have also been identified in ESTs obtained from cow, pig, and schistosomes. Phylogenetic analysis indicates that PF2 is more closely related to the vertebrate Gas11/Gas8 sequences than to the fly or trypanosome homologues ([Fig. 7](#fig7){ref-type="fig"} B). No PF2 homologues have been identified in either yeast or *Caenorhabditis elegans*. However, high levels of *Gas11/Gas8* transcripts have been detected in numerous vertebrate cells and tissues that do not assemble motile axonemes ([@bib55]; [@bib60]; unpublished data). PF2 homologues may therefore have additional functions in differentiated cells of higher organisms (see Discussion).

Discussion
==========

The *PF2* locus encodes an axonemal component required for assembly of the DRC
------------------------------------------------------------------------------

The CP, RS, and DRC are key elements in a signal transduction pathway that regulates dynein arm activity to produce the complex waveforms characteristic of eukaryotic cilia and flagella (for reviews see [@bib40]; [@bib18]). To better understand the role of the individual DRC subunits in this pathway, we used insertional mutagenesis strategies to isolate tagged mutations and thereby cloned the *PF2* locus. This is the first DRC gene and gene product to be characterized at both the molecular and cellular levels.

*pf2* mutants fail to assemble five of the seven DRC-associated subunits ([Table I](#tbl1){ref-type="table"}; [@bib36]) and display both reduced swimming velocities and aberrant waveforms with reduced shear amplitudes ([@bib3]; [@bib10]). Our work demonstrates that *PF2* encodes an ∼55-kD polypeptide that is uniformly distributed along the length of the axoneme and in the basal body region ([Figs. 4](#fig4){ref-type="fig"} and [5](#fig5){ref-type="fig"}). These results are consistent with the localization of the DRC ([@bib10]) and a prediction based on dikaryon rescue experiments that *PF2* might encode DRC subunit 4 ([@bib36]). In addition, transformation of *pf2* mutants with the wild-type *PF2* gene restores both wild-type flagellar motility and the missing DRC structure ([Figs. 1](#fig1){ref-type="fig"} and [3](#fig3){ref-type="fig"}). Thus, PF2 is required for proper assembly of DRC components and the regulation of flagellar motility.

The predicted structure of the PF2 polypeptide contains several coiled-coil domains ([Fig. 4](#fig4){ref-type="fig"}) that could play a role in protein--protein interactions. The most likely candidates for such interactions would be other components of the DRC and/or tubulin subunits of the outer doublets. Preliminary experiments using the zero-length cross-linker EDC suggest that PF2 may not directly interact with α- or β-tubulin ([Fig. 6](#fig6){ref-type="fig"}), but whether an interaction might be identified using other cross-linking agents remains to be determined. However, a close association between PF2 and at least three polypeptides has been identified, based on the relative mobility of three cross-linked products that react with an antibody specific for the HA-tagged PF2 ([Fig. 6](#fig6){ref-type="fig"}). The identities of the three polypeptides are unknown, but their apparent sizes are similar to those reported for three DRC subunits, DRC1, DRC2, and DRC3 ([Table I](#tbl1){ref-type="table"}; [@bib36]). Further confirmation will require the development of specific probes for these other DRC subunits. Nonetheless, these results, together with previous observations that *pf2* axonemes lack five different polypeptides (DRC3--DRC7) ([@bib16]; [@bib35], [@bib36]), indicate that the DRC is a discrete axonemal structure.

The function of PF2-related proteins in other species
-----------------------------------------------------

Close homologues of PF2 have been found in a variety of organisms ([Fig. 7](#fig7){ref-type="fig"}) and include the growth arrest--specific gene product known as Gas8 (mice) or Gas11 (humans) ([@bib2]; [@bib55]; [@bib60]), the trypanosome protein known as the T lymphocyte triggering factor (TLTF) or trypanin ([@bib53]; [@bib15]; [@bib17]), and several Gas8/Gas11-related sequences in insects, fish, protozoa, and other mammals. The remarkably high degree of sequence conservation ([Fig. 7](#fig7){ref-type="fig"} A) suggests a highly conserved cellular function.

*Gas8* was first described as a gene whose expression in mouse fibroblasts was activated during growth arrest induced by serum starvation ([@bib2]; [@bib23]). Recent work has shown that both *Gas8* mRNA and Gas8 protein are highly enriched in adult mouse testes ([@bib60]). Gas8 has been localized along the length of sperm flagella, but it is also found in the apical region of ciliated epithelia that line the respiratory and female reproductive tracts ([@bib60]). The pattern of localization for Gas8 is similar to that observed for PF2 ([Fig. 5](#fig5){ref-type="fig"}) and indicates that both polypeptides are conserved components of motile axonemes.

The human homologue, *Gas11*, was tentatively identified as a candidate tumor suppressor gene based on its location at a chromosome locus (16q24.3) commonly deleted in breast and prostate carcinomas, and the expression of its mouse orthologue during growth arrest ([@bib55]). Gas11 has since been localized in developing sperm, but its distribution in other human tissues has not been analyzed ([@bib60]). Interestingly, however, overexpression of a highly conserved region of Gas11 (aa 115--228; [Fig. 7](#fig7){ref-type="fig"}) resulted in the colocalization of a Gas11--GFP fusion protein with the plus ends of cytoplasmic microtubules in both trypanosomes and cultured mammalian cells ([@bib14], [@bib15]). These observations prompted the suggestion that the conserved region might serve as a novel microtubule-binding domain and that Gas11 may function as a microtubule-specific cytoskeletal linker protein ([@bib14], [@bib15]). A similar domain is present in PF2 (aa 114--227), but its function is unknown ([Fig. 7](#fig7){ref-type="fig"}).

*Gas8* and *Gas11* transcripts have previously been detected in a variety of tissues that do not assemble motile axonemes ([@bib55]; [@bib60]). We repeated these experiments using a mouse *Gas8* probe and found high levels of *Gas8* transcripts not only in mouse testis, lung, and brain, but also in heart, liver, and kidney (unpublished data). What might be the origin of *PF2*-related transcripts in these tissues? One possibility might be that all of these tissues contain cells that assemble immotile, primary cilia (see [www.wadsworth.org/bms/SCBlinks/cilial1.html](http://www.wadsworth.org/bms/SCBlinks/cilial1.html)). Although primary cilia typically lack the CP, RS, and dynein arms, it is possible that some DRC subunits may have been retained within the axoneme structure. If so, it would be reasonable to identify *PF2*-related transcripts in those tissues that assemble significant levels of primary cilia. Further work is needed to determine if Gas8/Gas11 is found in primary cilia or centrioles in mammalian cells. If present, this may account for the activation of *Gas8* expression observed in growth-arrested fibroblasts ([@bib2]; [@bib60]). Previous studies have shown that maximal assembly of primary cilia in these cells is closely correlated with withdrawal from the cell cycle and/or growth to confluence ([@bib52]; [@bib54]). Recent work has also revealed that primary cilia can serve as sensory organelles, relaying signals from receptors in the cilium membrane and thereby allowing cells to monitor their local environment and respond appropriately ([@bib25]). An exciting possibility is that signals received by primary cilia may influence the growth arrest process ([@bib54]; [@bib32]).

An alternative hypothesis would be that the mammalian homologues Gas8 and Gas11 have other, yet unidentified, cytoplasmic functions distinct from their role in the axoneme. The observation that a conserved domain can direct a Gas11 fusion protein to colocalize with the plus ends of microtubules in tissue culture cells ([@bib15]) may support this hypothesis. Additional work is clearly needed to more firmly establish the subcellular distribution of Gas8/Gas11 in mammalian cells.

PF2 is also closely related to a trypanosome protein, trypanin (formerly called TLTF). TLTF was first identified as a polypeptide released by *T. brucei* that triggers CD8^+^ T lymphocytes to proliferate and secrete γ-interferon ([@bib53]). Initial studies of a GFP-tagged TLTF fusion protein suggested that TLTF was localized to the flagellar pocket, a region formed by an invagination of the cell membrane at the site where the flagellum emerges from the cell body ([@bib14]). More recent work has shown that TLTF/trypanin is a component of the trypanosome cytoskeleton ([@bib15]), where it is distributed along the length of the flagellum (similar to both Gas8 and PF2) and may be associated with a region known as the flagellar attachment site ([@bib17]).

Interestingly, knockout of trypanin expression by RNA interference has shown that trypanin is required for directional cell motility of the trypanosome ([@bib17]). Trypanin(−) mutants do not have paralyzed flagella, but they have lost the ability to coordinate their flagellar beat and thus cannot generate productive cell motility. Analysis by transmission EM failed to identify a clear defect in axoneme structure. However, scanning EM indicated that the flagellum was partially detached from the cell in ∼28% of the trypanin(−) strains as compared with ∼8% in control strains. [@bib17] therefore proposed that trypanin is a novel cytoskeletal linker protein critical for linking the flagellum to the underlying cytoskeleton.

Based on the similarities between PF2 and trypanin, we favor an alternative interpretation of the trypanin(−) phenotype. First, trypanin is likely to be a component of the DRC in the trypanosome axoneme. The EM methods used by [@bib17] to analyze trypanin(−) axonemes would probably not be sensitive enough to resolve subtle defects in DRC structure. The identification of structural defects in *pf2* axonemes required the use of image-averaging procedures ([@bib24]; [@bib10]). Second, the apparent defect in flagellar attachment to the cell body could be a consequence of the aberrant flagellar motility in the trypanin(−) cells. This interpretation is consistent with the swimming behavior of the trypanin(−) strains ([@bib17]), the motility phenotypes of *pf2* mutants in *Chlamydomonas* ([@bib3]; [@bib24]; [@bib10]), and the present study.

Role of the DRC and its constituent polypeptides
------------------------------------------------

The absence of a functional PF2 protein results in the inability of *pf2* strains to assemble a major portion of the DRC ([@bib10]; [@bib36]). The mutant cells also display an unusual motility phenotype ([@bib3]). When combined with a CP- or RS-associated paralyzed flagellar mutation, *pf2* mutations restore partial flagellar motility without restoring the missing CP or RS structures ([@bib16]; [@bib35]). The suppression of flagellar paralysis has led to the hypothesis that the DRC is a part of a signal transduction pathway that controls motility by regulating dynein activity (for review see [@bib40]). The DRC apparently serves this function by acting as an intermediate in the pathway, receiving signals from the CP/RS structures and then distributing them appropriately to the dynein arms.

We propose that *PF2* encodes a DRC polypeptide that is involved in stabilizing the complex by interacting with other DRC subunits. This proposal is supported by the observations that *pf2* axonemes lack four additional DRC subunits ([@bib36]), PF2 can be cross-linked to at least three axonemal polypeptides ([Fig. 6](#fig6){ref-type="fig"}), and coiled-coil domains are present within the PF2 structure ([Fig. 4](#fig4){ref-type="fig"}). We suggest that PF2 serves as a molecular scaffold, whose function is to appropriately localize other components within the axoneme, in a manner similar to that suggested for the CP-associated protein PF6 ([@bib42]) and the RS-associated protein RSP3 ([@bib9]). Other DRC subunits could therefore be positioned to interact with the network of regulatory enzymes and thus regulate motility by controlling the phosphorylation state of key axonemal polypeptides. This model is also consistent with observations indicating that the DRC plays an important role in stabilizing the assembly of specific inner arm isoforms ([@bib10]; [@bib36]). Alternatively, PF2 might also serve as a mechanical sensor or molecular spring that senses tension during axonemal bending and thereby influences the activity of nearby dynein isoforms. Future studies to identify and characterize other subunits of the DRC that interact with PF2 will be needed to test these various models.

Materials and methods
=====================

Mutant strains and genetic analyses
-----------------------------------

Strains listed in [Table II](#tbl2){ref-type="table"} were maintained as previously described ([@bib42]). The motility mutant 9B11 was generated by transformation of a *nit1*-*305* strain with the plasmid pMN24 containing a wild-type copy of the *NIT1* gene ([@bib7]). The *NIT1* plasmid was inserted into the *PF2* locus ([Fig. 1](#fig1){ref-type="fig"}), and so 9B11 is now known as *pf2-4*. Other strains were obtained from the *Chlamydomonas* Genetics Center.

To determine whether the motility phenotype of 9B11 was linked to the *NIT1* plasmid used as a selectable marker, 9B11 was backcrossed to a *nit* ^−^ strain, and the resulting progeny were analyzed for cosegregation of their motility phenotypes and their ability to grow on selective media. Out of 56 progeny obtained from seven complete octads, 28 were *nit* ^+^ and swam slowly, whereas all 28 *nit* ^−^ strains had wild-type motility.

Isolation of genomic sequence flanking the *NIT1* plasmid
---------------------------------------------------------

Purification of genomic DNA, restriction enzyme digests, agarose gels, isolation of total RNA, preparation of cDNA, PCR reactions, and Southern and Northern blots were performed as previously described ([@bib42]). To identify genomic DNA flanking the site of the plasmid insertion, wild-type and 9B11 genomic DNA were analyzed on Southern blots, and a 6.2-kb BamHI fragment unique to 9B11 was identified by hybridization with a 3.2-kb probe derived from the 3′ end of *NIT1*. The 6.2-kb BamHI fragment was recovered by screening a size-fractionated minilibrary with the *NIT1* probe as previously described ([@bib42]). Positive clones were digested with several restriction enzymes and probed with *NIT1* to identify a unique 0.45-kb NotI/BamHI fragment containing only 9B11 genomic DNA. Southern blot analysis confirmed that this fragment, designated FC-1, was located close to the site of *NIT1* insertion ([Fig. 1](#fig1){ref-type="fig"}).

Recovery of the wild-type *PF2* gene
------------------------------------

A large-insert, wild-type (21gr), genomic library constructed in λFIX II ([@bib47]) was screened with FC-1 as previously described ([@bib42]). 13 phage clones were recovered and restriction mapped. Selected subclones were sequenced and analyzed for potential open reading frames as previously described ([@bib42]). 9.3 kb of genomic sequence has been deposited under GenBank/EMBL/DDBJ accession nos. [AY309087](AY309087)--[AY309089](AY309089). An incomplete version of the sequence is also present in the recently released draft of the *Chlamydomonas* genome (<http://genome.jgi-psf.org/chlre1/chlre1.home.html>).

To place the sequence on the genetic map, a genomic fragment was used to identify a PvuII restriction fragment length polymorphism between two strains, 137c and S1-D2. The fragment was then hybridized to a series of mapping filters containing DNA isolated from tetrad progeny of crosses between multiply marked *C. reinhardtii* strains and S1-D2. The segregation of the PvuII polymorphism was analyzed relative to the segregation of \>42 genetic and molecular markers ([@bib39]). The sequence is linked to the molecular marker *CRY1* (∼9.4 cM) and the motility mutation *pf2-1* (\<5.5 cM).

To test whether any of the clones could rescue the motility defects in *pf2-4* and other *pf2* mutants, *pf2 arg* strains were cotransformed with pARG7.8 (containing a wild-type copy of the *ARG7* gene; [@bib5]) and the clone in question. Transformants were selected on media lacking arginine and then screened for recovery of wild-type motility ([@bib42]).

Construction of an epitope-tagged gene construct
------------------------------------------------

To determine whether PF2 was a structural component of the axoneme, a modified *PF2* gene containing three consecutive HA epitopes was constructed. A 6.9-kb XmaI fragment containing the complete *PF2* transcription unit was subcloned from the rescuing phage clone, λG2, into pUC119 to form the plasmid p9B11-X1.2. A sequence encoding a triple HA epitope (p3HA) was PCR amplified from a second plasmid provided by M. Lavoie and C. Silflow (University of Minnesota, St. Paul, MN) using primers with BstEII restriction sites. A 250-bp product containing the triple HA epitope was ligated into pGEM-T Easy (Promega), released with BstEII, and then religated into a unique BstEII site in p9B11-X1.2, yielding the epitope-tagged *PF2* gene, p9-3HA. Sequence analysis confirmed that the epitope tag was inserted into the 12th exon in the proper orientation and reading frame.

Fractionation of flagella and biochemical analyses
--------------------------------------------------

Axonemes were isolated from vegetative cells ([@bib37]; [@bib42]) and analyzed on either 7.5% polyacrylamide or 5--15% acrylamide, 0--2.4 M glycerol gradient gels using the [@bib21] buffer system. Gels were stained directly or transferred to Immobilon-P (Millipore). Total protein on the blots was visualized with Blot FastStain (Chemicon International). Western blots were probed with a high affinity rat antibody directed against the HA epitope (clone 3F10; Roche Molecular Biochemicals). Immunoreactive bands were detected using an alkaline phosphatase--conjugated secondary antibody ([@bib42]).

To identify polypeptides that associate with PF2, axonemes from the HA-tagged, *pf2-4* rescued strain were prepared in buffer lacking DTT. Chemical cross-linking was performed by treating axoneme samples with EDC (Pierce Chemical Co.) for 1 h at room temperature ([@bib20]). The reaction was terminated by the addition of a 10-fold molar excess of β-mercaptoethanol. Western blots were probed with antisera directed against either the HA epitope, α-tubulin (YOL 1/34; Accurate Chemical Co.), or β-tubulin (Tu27B; a gift of L.I. Binder, Northwestern University, Evanston, IL), and the appropriate secondary antibody.

Electron and light microscopy
-----------------------------

Axonemes were prepared for EM as described by [@bib37]. The methods for digitization and image averaging were as previously described ([@bib24]; [@bib28]). Analysis of axoneme cross sections indicated that the structural defects in *pf2-4* were similar to those seen previously with *pf2-1*, but potential differences between proximal and distal regions were not examined. Control and HA-tagged strains were prepared for immunofluorescence using an ice-cold methanol fixation protocol described by [@bib45]. Fixed cells were stained with a primary antibody directed against the HA epitope and an Alexa^®^488 secondary antibody as previously described ([@bib42]; [@bib33]).
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